These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10848224)

  • 1. Neuroprotection: is it already applicable to glaucoma therapy?
    Ritch R
    Curr Opin Ophthalmol; 2000 Apr; 11(2):78-84. PubMed ID: 10848224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.
    Neufeld AH
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S129-35. PubMed ID: 10416755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection in relation to retinal ischemia and relevance to glaucoma.
    Osborne NN; Ugarte M; Chao M; Chidlow G; Bae JH; Wood JP; Nash MS
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S102-28. PubMed ID: 10416754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
    Guo L; Salt TE; Maass A; Luong V; Moss SE; Fitzke FW; Cordeiro MF
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):626-33. PubMed ID: 16431960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
    Vorwerk CK; Gorla MS; Dreyer EB
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S142-50. PubMed ID: 10416757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prodrug of a selective inhibitor of inducible nitric oxide synthase is neuroprotective in the rat model of glaucoma.
    Neufeld AH; Das S; Vora S; Gachie E; Kawai S; Manning PT; Connor JR
    J Glaucoma; 2002 Jun; 11(3):221-5. PubMed ID: 12140399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroprotection in glaucoma. What is the current status?].
    Haefliger IO; Pellanda N; Fleischhauer JC; Gekkieva M; Flammer J
    Ophthalmologe; 2001 Jun; 98(6):564-7. PubMed ID: 11450482
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
    Hartwick AT
    Optom Vis Sci; 2001 Feb; 78(2):85-94. PubMed ID: 11265931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cannabinoid applications in glaucoma].
    Pinar-Sueiro S; Rodríguez-Puertas R; Vecino E
    Arch Soc Esp Oftalmol; 2011 Jan; 86(1):16-23. PubMed ID: 21414525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saving the nerve from glaucoma: memantine to caspaces.
    Naskar R; Vorwerk CK; Dreyer EB
    Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The option of neuroprotective therapeutics for glaucoma].
    Xiong S; Xu X
    Zhonghua Yan Ke Za Zhi; 2014 Aug; 50(8):630-3. PubMed ID: 25385383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection.
    Russo R; Cavaliere F; Rombolà L; Gliozzi M; Cerulli A; Nucci C; Fazzi E; Bagetta G; Corasaniti MT; Morrone LA
    Prog Brain Res; 2008; 173():575-82. PubMed ID: 18929135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina.
    Lambuk L; Jafri AJ; Arfuzir NN; Iezhitsa I; Agarwal R; Rozali KN; Agarwal P; Bakar NS; Kutty MK; Yusof AP; Krasilnikova A; Spasov A; Ozerov A; Ismail NM
    Neurotox Res; 2017 Jan; 31(1):31-45. PubMed ID: 27568334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arundic acid attenuates retinal ganglion cell death by increasing glutamate/aspartate transporter expression in a model of normal tension glaucoma.
    Yanagisawa M; Aida T; Takeda T; Namekata K; Harada T; Shinagawa R; Tanaka K
    Cell Death Dis; 2015 Mar; 6(3):e1693. PubMed ID: 25789968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin: a novel neuroprotectant for the treatment of glaucoma.
    Belforte NA; Moreno MC; de Zavalía N; Sande PH; Chianelli MS; Keller Sarmiento MI; Rosenstein RE
    J Pineal Res; 2010 May; 48(4):353-64. PubMed ID: 20374442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
    Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects for neuroprotective glaucoma therapy].
    Grehn F
    Ophthalmologe; 2001 Oct; 98(10):925-8. PubMed ID: 11699312
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroprotective Strategies in Glaucoma.
    Gossman CA; Christie J; Webster MK; Linn DM; Linn CL
    Curr Pharm Des; 2016; 22(14):2178-92. PubMed ID: 26818878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.